Company / Accounts Receivable
Tanke Biosciences Corp Accounts Receivable History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$2.0M
FY2012
5-year range
$1.9M / $2.0M
FY2011-FY2012
Trend
+3.6%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$2M in FY2012.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2012, accounts receivable increased 3.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2012 | $2.0M | +3.6% |
| FY2011 | $1.9M | - |
As of FY2012 · SEC 10-K · Updated Jun 29, 2026